Log in

NASDAQ:IMRN - IMMURON LTD/S Stock Price, Forecast & News

0.00 (0.00 %)
(As of 02/19/2020 03:24 AM ET)
Today's Range
Now: $3.72
50-Day Range
MA: $3.57
52-Week Range
Now: $3.72
Volume528 shs
Average Volume10,038 shs
Market Capitalization$13.32 million
P/E RatioN/A
Dividend YieldN/A
Immuron Limited, a biopharmaceutical company, focuses on the research and development of immunomodulatory polyclonal antibodies for the treatment and prevention of various diseases through its oral immunoglobulins platform in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company markets Travelan for the prevention of travelers' diarrhea. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:IMRN



Sales & Book Value

Annual Sales$1.71 million
Book Value$1.47 per share



Market Cap$13.32 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IMRN News and Ratings via Email

Sign-up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter.

IMMURON LTD/S (NASDAQ:IMRN) Frequently Asked Questions

What is IMMURON LTD/S's stock symbol?

IMMURON LTD/S trades on the NASDAQ under the ticker symbol "IMRN."

Has IMMURON LTD/S been receiving favorable news coverage?

News stories about IMRN stock have been trending very negative on Wednesday, according to InfoTrie. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. IMMURON LTD/S earned a media sentiment score of -3.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the company's share price in the near future. View News Stories for IMMURON LTD/S.

Who are some of IMMURON LTD/S's key competitors?

What other stocks do shareholders of IMMURON LTD/S own?

Who are IMMURON LTD/S's key executives?

IMMURON LTD/S's management team includes the folowing people:
  • Mr. Peter Anastasiou, Exec. Vice Chairman (Age 59)
  • Dr. Jerry Kanellos Ph.D., Chief Operating Officer (Age 58)
  • Dr. Gary S. Jacob, CEO & Director (Age 72)
  • Mr. Phillip Allen Hains, CFO & Company Sec. (Age 60)
  • Mr. David Lyon, Head of Marketing


(IMRN) raised $6 million in an initial public offering on Friday, June 9th 2017. The company issued 600,000 shares at a price of $9.99 per share. Joseph Gunnar and Rodman & Renshaw (a unit of H.C. Wainwright & Co.) served as the underwriters for the IPO and WallachBeth Capital was co-manager.

Who are IMMURON LTD/S's major shareholders?

IMMURON LTD/S's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (0.28%).

Which major investors are buying IMMURON LTD/S stock?

IMRN stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

How do I buy shares of IMMURON LTD/S?

Shares of IMRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is IMMURON LTD/S's stock price today?

One share of IMRN stock can currently be purchased for approximately $3.72.

How big of a company is IMMURON LTD/S?

IMMURON LTD/S has a market capitalization of $13.32 million and generates $1.71 million in revenue each year. View Additional Information About IMMURON LTD/S.

What is IMMURON LTD/S's official website?

The official website for IMMURON LTD/S is http://www.immuron.com.au/.

How can I contact IMMURON LTD/S?

IMMURON LTD/S's mailing address is 62 LYGON STREET LEVEL 3, CARLTON C3, 3053. The company can be reached via phone at 610398245254 or via email at [email protected]

MarketBeat Community Rating for IMMURON LTD/S (NASDAQ IMRN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  180 (Vote Outperform)
Underperform Votes:  167 (Vote Underperform)
Total Votes:  347
MarketBeat's community ratings are surveys of what our community members think about IMMURON LTD/S and other stocks. Vote "Outperform" if you believe IMRN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMRN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel